JP5768070B2 - フロースルー式での生物製剤からのタンパク質凝集体の除去 - Google Patents

フロースルー式での生物製剤からのタンパク質凝集体の除去 Download PDF

Info

Publication number
JP5768070B2
JP5768070B2 JP2013027361A JP2013027361A JP5768070B2 JP 5768070 B2 JP5768070 B2 JP 5768070B2 JP 2013027361 A JP2013027361 A JP 2013027361A JP 2013027361 A JP2013027361 A JP 2013027361A JP 5768070 B2 JP5768070 B2 JP 5768070B2
Authority
JP
Japan
Prior art keywords
protein
membrane
aggregates
flow
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013027361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013189427A (ja
Inventor
ミハイル・コズロフ
ウイリアム・カタルド
アジシユ・ポテイ
ケビン・ガリポー
ジエームズ・ハムジク
ホアキン・ウマーナ
ラルス・ピーク
Original Assignee
メルク パテント ゲーエムベーハー
メルク パテント ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メルク パテント ゲーエムベーハー, メルク パテント ゲーエムベーハー filed Critical メルク パテント ゲーエムベーハー
Publication of JP2013189427A publication Critical patent/JP2013189427A/ja
Application granted granted Critical
Publication of JP5768070B2 publication Critical patent/JP5768070B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/58—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing oxygen in addition to the carbonamido oxygen, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine
    • C08F220/585—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing oxygen in addition to the carbonamido oxygen, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine and containing other heteroatoms, e.g. 2-acrylamido-2-methylpropane sulfonic acid [AMPS]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/16—Organic material
    • B01J39/18—Macromolecular compounds
    • B01J39/20—Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/02—Column or bed processes
    • B01J47/026—Column or bed processes using columns or beds of different ion exchange materials in series
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/36—Amides or imides
    • C08F222/38—Amides
    • C08F222/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Graft Or Block Polymers (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013027361A 2012-03-12 2013-02-15 フロースルー式での生物製剤からのタンパク質凝集体の除去 Active JP5768070B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261609533P 2012-03-12 2012-03-12
US61/609,533 2012-03-12
US201261666578P 2012-06-29 2012-06-29
US61/666,578 2012-06-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015000657A Division JP6231027B2 (ja) 2012-03-12 2015-01-06 フロースルー式での生物製剤からのタンパク質凝集体の除去

Publications (2)

Publication Number Publication Date
JP2013189427A JP2013189427A (ja) 2013-09-26
JP5768070B2 true JP5768070B2 (ja) 2015-08-26

Family

ID=48044702

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013027361A Active JP5768070B2 (ja) 2012-03-12 2013-02-15 フロースルー式での生物製剤からのタンパク質凝集体の除去
JP2015000657A Active JP6231027B2 (ja) 2012-03-12 2015-01-06 フロースルー式での生物製剤からのタンパク質凝集体の除去
JP2017200909A Active JP6580650B2 (ja) 2012-03-12 2017-10-17 フロースルー式での生物製剤からのタンパク質凝集体の除去

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015000657A Active JP6231027B2 (ja) 2012-03-12 2015-01-06 フロースルー式での生物製剤からのタンパク質凝集体の除去
JP2017200909A Active JP6580650B2 (ja) 2012-03-12 2017-10-17 フロースルー式での生物製剤からのタンパク質凝集体の除去

Country Status (10)

Country Link
US (2) US20130245139A1 (ko)
EP (3) EP3312190B1 (ko)
JP (3) JP5768070B2 (ko)
KR (4) KR101520753B1 (ko)
CN (3) CN110256628A (ko)
ES (2) ES2812648T3 (ko)
PL (1) PL2639239T3 (ko)
SG (1) SG10201701224UA (ko)
SI (1) SI2639239T1 (ko)
WO (1) WO2013138098A1 (ko)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012015908A2 (en) 2010-07-30 2012-02-02 Millipore Corporation Chromatography media and method
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013028330A2 (en) * 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
KR102196230B1 (ko) 2012-09-17 2020-12-29 더블유.알. 그레이스 앤드 캄파니-콘. 크로마토그래피 매질 및 장치
AU2013381687A1 (en) 2013-03-12 2015-09-24 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
PT2969099T (pt) * 2013-03-14 2018-07-05 Amgen Inc Remoção de ligandos escapados de cromatografia de afinidade
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
KR101975771B1 (ko) * 2013-12-12 2019-05-09 이엠디 밀리포어 코포레이션 아크릴아미드 함유 필터를 사용한 단백질 분리
EP3094390B1 (en) 2014-01-16 2021-07-07 W.R. Grace & CO. - CONN. Affinity chromatography media and chromatography devices
CN105940104B (zh) * 2014-01-31 2020-01-10 恩制因塞米公司 固定化蛋白质及其用途
CN107847907A (zh) 2014-05-02 2018-03-27 格雷斯公司 官能化载体材料以及制备和使用官能化载体材料的方法
EP3173783B1 (en) * 2014-07-25 2019-02-27 Asahi Kasei Medical Co., Ltd. Cation-exchange chromatography support and method for using same
JP6652554B2 (ja) * 2014-09-02 2020-02-26 イー・エム・デイー・ミリポア・コーポレイシヨン ナノフィブリル化表面特徴を有する高表面積繊維媒体
KR102162753B1 (ko) 2014-12-08 2020-10-07 이엠디 밀리포어 코포레이션 혼합층 이온 교환 흡착제
JPWO2016093251A1 (ja) * 2014-12-08 2017-05-25 旭化成メディカル株式会社 生理活性物質の精製方法
JP2016210705A (ja) * 2015-04-30 2016-12-15 昭和電工株式会社 タンパク質凝集体の除去方法
KR102566292B1 (ko) 2015-06-05 2023-08-10 더블유.알. 그레이스 앤드 캄파니-콘. 흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법
CN108350026A (zh) * 2015-11-18 2018-07-31 默克专利股份公司 离子交换色谱法中改进的蛋白质分离
CN106807330A (zh) * 2015-11-27 2017-06-09 中国科学院大连化学物理研究所 一种规整结构吸附材料的制备及吸附材料和应用
JP6621176B2 (ja) * 2016-01-22 2019-12-18 旭化成メディカル株式会社 タンパク質の精製方法
JP7032046B2 (ja) * 2016-01-22 2022-03-08 旭化成メディカル株式会社 生理活性物質の連続的な定流速精製方法
WO2017126496A1 (ja) * 2016-01-22 2017-07-27 旭化成メディカル株式会社 タンパク質の精製方法
EP3275897A1 (en) * 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
WO2018043645A1 (ja) * 2016-08-31 2018-03-08 協和発酵キリン株式会社 活性炭を用いた蛋白質の精製方法
US11446613B2 (en) 2016-09-09 2022-09-20 3M Innovative Properties Company Functionalized copolymers and use thereof
EP3511710B1 (en) 2016-09-09 2021-03-03 Asahi Kasei Medical Co., Ltd. Strong cation exchange chromatography carrier and use of same
JP7138096B2 (ja) * 2016-09-09 2022-09-15 スリーエム イノベイティブ プロパティズ カンパニー 生物学的溶液中の単量体タンパク質から凝集タンパク質を分離するための方法
KR20190076046A (ko) * 2016-11-10 2019-07-01 산도즈 아게 단백질 용액의 탈염 공정
EP3758839A1 (en) 2018-02-27 2021-01-06 Life Technologies Corporation Flocculant functionalized separation media
CN111818980B (zh) * 2018-03-08 2022-10-11 生物辐射实验室股份有限公司 阴离子交换-疏水混合模式色谱树脂
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
WO2019192877A1 (en) 2018-04-03 2019-10-10 Merck Patent Gmbh Cex chromatography media and low salt elution of target proteins from biopharmaceutical feeds
US11045773B2 (en) * 2018-08-31 2021-06-29 Pall Corporation Salt tolerant porous medium
DE102018009597A1 (de) * 2018-12-07 2020-06-10 Sartorius Stedim Biotech Gmbh Vorrichtung und Verfahren zur mehrfachen Änderung der Zusammensetzung eines Fluids
SG11202107192VA (en) * 2019-01-23 2021-07-29 Daiichi Sankyo Co Ltd Methods for purifying antibodies comprising of a process by using activated carbon materials
US10981950B2 (en) 2019-01-31 2021-04-20 Joanna Pezzini Therapeutic protein flow kit for a continuous purification system
US11896969B2 (en) 2019-09-05 2024-02-13 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resins
CA3162172A1 (en) 2019-11-22 2021-05-27 Morphosys Ag Method to increase antibody yield during ion exchange chromatography
CN115397834A (zh) * 2020-04-13 2022-11-25 3M创新有限公司 用于纯化目标分子的流通方法和装置
WO2021232009A1 (en) * 2020-05-15 2021-11-18 Stevenson Gary L Multistage oil reclamation system
CN113416235B (zh) * 2021-06-24 2023-04-25 苏州赛分科技股份有限公司 用于纯化分离病毒类抗原的液相色谱法
CN113522256B (zh) * 2021-07-19 2022-06-21 中国科学院兰州化学物理研究所 一种水凝胶@二氧化硅液相色谱填料的制备及应用
TW202323268A (zh) 2021-08-23 2023-06-16 美商建南德克公司 用於抗體藥物結合物之流通陽離子交換層析純化製程
AU2021471146A1 (en) * 2021-10-27 2024-06-13 Plasma Technologies, Llc Compositions and methods for isolating proteins

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
US4944879A (en) 1989-07-27 1990-07-31 Millipore Corporation Membrane having hydrophilic surface
US6451260B1 (en) * 1997-08-26 2002-09-17 Dyax Corp. Method for producing microporous elements, the microporous elements thus produced and uses thereof
EP1500661A1 (en) 1998-06-01 2005-01-26 Genetech, Inc. Separation of protein monomers from aggregates by use of ion-exchange chromatography
US6783937B1 (en) * 1999-02-25 2004-08-31 Pall Corporation Negatively charged membrane
US6783713B2 (en) * 1999-05-03 2004-08-31 The Procter & Gamble Co. Filters for removal of pathogens from liquids
AUPQ389599A0 (en) * 1999-11-05 1999-12-02 Ilion Technology Corporation Polyelectrolyte gel
JP4918952B2 (ja) * 2001-03-28 2012-04-18 Ｄｉｃ株式会社 吸水性材料
US7318972B2 (en) * 2001-09-07 2008-01-15 Itm Power Ltd. Hydrophilic polymers and their use in electrochemical cells
AU2003212912A1 (en) 2002-02-04 2003-09-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
DE602004024190D1 (de) * 2003-02-19 2009-12-31 Natrix Separations Inc Geträgerte poröse gele umfassende verbundmaterialien
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
WO2005042569A1 (en) 2003-10-24 2005-05-12 Amgen, Inc. Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
AU2004286938B2 (en) * 2003-10-27 2011-06-30 Wyeth Removal of high molecular weight aggregates using hydroxyapatite chromatography
SE0302911D0 (sv) * 2003-10-31 2003-10-31 Amersham Biosciences Ab Novel separation matrix
KR101243425B1 (ko) * 2004-10-21 2013-03-13 지이 헬스케어 바이오-사이언시스 에이비 항체의 정제 방법
US20070012345A1 (en) * 2005-01-24 2007-01-18 Owens Tony L Lower limb-support ambulatory device
RU2457214C2 (ru) 2005-03-11 2012-07-27 Вайет Способ хроматографии в режиме слабого распределения
EP1907089B1 (en) * 2005-07-28 2011-11-23 Bio-Rad Laboratories, Inc. Separation of proteins based on isoelectric point using solid-phase buffers
US7674836B2 (en) * 2006-07-28 2010-03-09 3M Innovative Properties Company Method of making macroporous cation exchange resins
FI2061803T4 (fi) * 2006-08-28 2023-03-14 Process for the purification of fc-containing proteins
DE102006061327A1 (de) * 2006-12-22 2008-06-26 Basf Construction Polymers Gmbh Pfropf-Copolymer, Verfahren zu dessen Herstellung und seine Verwendung
JP2010515917A (ja) * 2007-01-10 2010-05-13 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー クロマトグラフィーレジン
DE102007012786A1 (de) * 2007-03-16 2009-01-08 Construction Research & Technology Gmbh Herstellung von sulfogruppenhaltigen Copolymeren
US20080257814A1 (en) 2007-04-23 2008-10-23 Millipore Corporation Filtration Cartridge
EP2152405B2 (de) * 2007-05-25 2017-04-05 Merck Patent GmbH Mischpfropfpolymere für die kationenaustauschchromatographie
AU2008256411B2 (en) * 2007-06-01 2013-08-22 F. Hoffmann-La Roche Ag Immunoglobulin purification
EP2227314B1 (en) 2007-10-03 2017-10-25 EMD Millipore Corporation Stacked plates filtration cartridge
JP5132278B2 (ja) * 2007-11-28 2013-01-30 一般財団法人川村理化学研究所 有機無機複合ヒドロゲルの製造方法
US8288041B2 (en) 2008-02-19 2012-10-16 Bloom Energy Corporation Fuel cell system containing anode tail gas oxidizer and hybrid heat exchanger/reformer
EP2153877A1 (de) * 2008-07-30 2010-02-17 MERCK PATENT GmbH Mischpfropfpolymere für die Ionenaustauschchromatographie
AU2008221604B2 (en) * 2008-09-22 2010-04-22 Commonwealth Scientific And Industrial Research Organisation Temperature-responsive polymer particles in protein separation applications
US20130056415A1 (en) * 2009-02-27 2013-03-07 Mikhail Kozlov Negatively charged porous medium for removing protein aggregates
WO2010133527A2 (de) * 2009-05-20 2010-11-25 Basf Se Hydrophob assoziierende copolymere
IN2012DN00338A (ko) * 2009-08-07 2015-05-22 Millipore Corp
US20110301333A1 (en) * 2010-06-08 2011-12-08 Millipore Corporation Removal of protein aggregates from biopharmaceutical preparations using calcium phosphate salts
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
KR20130028939A (ko) * 2010-07-29 2013-03-20 이엠디 밀리포어 코포레이션 크로마토그래피 매질 성능을 개선하기 위한 그라프팅 방법
WO2012015908A2 (en) * 2010-07-30 2012-02-02 Millipore Corporation Chromatography media and method

Also Published As

Publication number Publication date
KR20140141562A (ko) 2014-12-10
ES2644744T3 (es) 2017-11-30
CN104817611A (zh) 2015-08-05
KR20130105340A (ko) 2013-09-25
CN103382215A (zh) 2013-11-06
JP2015110786A (ja) 2015-06-18
KR20150043271A (ko) 2015-04-22
SG10201701224UA (en) 2017-04-27
KR101966692B1 (ko) 2019-04-09
SI2639239T1 (sl) 2017-12-29
EP2639239A3 (en) 2013-11-20
EP3312190B1 (en) 2020-05-27
WO2013138098A1 (en) 2013-09-19
US20130245139A1 (en) 2013-09-19
EP2639239B1 (en) 2017-09-06
KR101520753B1 (ko) 2015-05-15
KR101601812B1 (ko) 2016-03-10
JP2018048162A (ja) 2018-03-29
CN103382215B (zh) 2016-08-24
CN104817611B (zh) 2019-06-18
JP6231027B2 (ja) 2017-11-15
EP3312190A1 (en) 2018-04-25
CN110256628A (zh) 2019-09-20
ES2812648T3 (es) 2021-03-17
EP2639239A2 (en) 2013-09-18
KR20150093642A (ko) 2015-08-18
US20180215786A1 (en) 2018-08-02
JP2013189427A (ja) 2013-09-26
JP6580650B2 (ja) 2019-09-25
EP3730510A1 (en) 2020-10-28
PL2639239T3 (pl) 2018-03-30

Similar Documents

Publication Publication Date Title
JP6580650B2 (ja) フロースルー式での生物製剤からのタンパク質凝集体の除去
JP6471183B2 (ja) 生体分子の精製
US11305271B2 (en) Chromatography media and method
KR102070566B1 (ko) 크로마토그래피 방법
US10570171B2 (en) Protein separations using an acrylamide containing filter
US7662930B2 (en) Polishing steps used in multi-step protein purification processes
JP2011036128A (ja) 抗体製造方法
JP2021519339A (ja) Ｃｅｘクロマトグラフィー媒体及び生物製剤供給原料からの標的タンパク質の低塩溶出

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130710

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20130710

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20130710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140708

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141002

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141007

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150602

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150622

R150 Certificate of patent or registration of utility model

Ref document number: 5768070

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250